agalsidase alfa
Commercial- Indications
- Fabry disease
Company intelligence / Profile preview
TKTX produces topical numbing creams and gels primarily for use in cosmetic procedures to reduce pain. Their products contain high concentrations of anesthetic agents like lidocaine. The FDA has issued a warning letter to the company regarding unapproved drug status and safety concerns due to excessive lidocaine content exceeding over-the-counter limits; these products may pose health risks if misused or applied on large/broken skin areas
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TKTX.